The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Autogenous Vaccines Market Research Report 2025
Synopsis
The autogenous vaccine is a vaccine prepared from cultures of microorganisms obtained from an individual and then used to immunize that same individual against further spread and progress of the same microorganisms.
The global Veterinary Autogenous Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 78%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Autogenous Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Autogenous Vaccines.
Report Scope
The Veterinary Autogenous Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Autogenous Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Autogenous Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ZOETIS
Ceva Biovac
Boehringer Ingelheim
Gallant Custom Laboratories
UVAXX
Bimeda
Dyntec
Elanco Animal Health
Vaxxinova
Hygieia Biological Laboratories
Deltamune Animal Health
Genova Labs
Newport Laboratories
Epitopix
LOHMANN TIERZUCHT
Addison Biological Laboratory
Phibro Animal Health Corporation
Segment by Type
Pet Vaccine
Livestock Vaccine
Segment by Application
Research Facility
Pet Clinic
Ranches
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Autogenous Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Autogenous Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The autogenous vaccine is a vaccine prepared from cultures of microorganisms obtained from an individual and then used to immunize that same individual against further spread and progress of the same microorganisms.
The global Veterinary Autogenous Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 78%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Autogenous Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Autogenous Vaccines.
Report Scope
The Veterinary Autogenous Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Autogenous Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Autogenous Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ZOETIS
Ceva Biovac
Boehringer Ingelheim
Gallant Custom Laboratories
UVAXX
Bimeda
Dyntec
Elanco Animal Health
Vaxxinova
Hygieia Biological Laboratories
Deltamune Animal Health
Genova Labs
Newport Laboratories
Epitopix
LOHMANN TIERZUCHT
Addison Biological Laboratory
Phibro Animal Health Corporation
Segment by Type
Pet Vaccine
Livestock Vaccine
Segment by Application
Research Facility
Pet Clinic
Ranches
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Autogenous Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Autogenous Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Veterinary Autogenous Vaccines Market Overview
1.1 Product Overview and Scope of Veterinary Autogenous Vaccines
1.2 Veterinary Autogenous Vaccines Segment by Type
1.2.1 Global Veterinary Autogenous Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Pet Vaccine
1.2.3 Livestock Vaccine
1.3 Veterinary Autogenous Vaccines Segment by Application
1.3.1 Global Veterinary Autogenous Vaccines Market Value by Application: (2024-2030)
1.3.2 Research Facility
1.3.3 Pet Clinic
1.3.4 Ranches
1.3.5 Others
1.4 Global Veterinary Autogenous Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary Autogenous Vaccines Revenue 2019-2030
1.4.2 Global Veterinary Autogenous Vaccines Sales 2019-2030
1.4.3 Global Veterinary Autogenous Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Veterinary Autogenous Vaccines Market Competition by Manufacturers
2.1 Global Veterinary Autogenous Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Veterinary Autogenous Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Veterinary Autogenous Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Veterinary Autogenous Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Autogenous Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Autogenous Vaccines, Product Type & Application
2.7 Veterinary Autogenous Vaccines Market Competitive Situation and Trends
2.7.1 Veterinary Autogenous Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Autogenous Vaccines Players Market Share by Revenue
2.7.3 Global Veterinary Autogenous Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Autogenous Vaccines Retrospective Market Scenario by Region
3.1 Global Veterinary Autogenous Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Veterinary Autogenous Vaccines Global Veterinary Autogenous Vaccines Sales by Region: 2019-2030
3.2.1 Global Veterinary Autogenous Vaccines Sales by Region: 2019-2024
3.2.2 Global Veterinary Autogenous Vaccines Sales by Region: 2025-2030
3.3 Global Veterinary Autogenous Vaccines Global Veterinary Autogenous Vaccines Revenue by Region: 2019-2030
3.3.1 Global Veterinary Autogenous Vaccines Revenue by Region: 2019-2024
3.3.2 Global Veterinary Autogenous Vaccines Revenue by Region: 2025-2030
3.4 North America Veterinary Autogenous Vaccines Market Facts & Figures by Country
3.4.1 North America Veterinary Autogenous Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Veterinary Autogenous Vaccines Sales by Country (2019-2030)
3.4.3 North America Veterinary Autogenous Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Autogenous Vaccines Market Facts & Figures by Country
3.5.1 Europe Veterinary Autogenous Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Veterinary Autogenous Vaccines Sales by Country (2019-2030)
3.5.3 Europe Veterinary Autogenous Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Autogenous Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Autogenous Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Veterinary Autogenous Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Veterinary Autogenous Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary Autogenous Vaccines Market Facts & Figures by Country
3.7.1 Latin America Veterinary Autogenous Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Veterinary Autogenous Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Veterinary Autogenous Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Autogenous Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Autogenous Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Veterinary Autogenous Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Veterinary Autogenous Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Autogenous Vaccines Sales by Type (2019-2030)
4.1.1 Global Veterinary Autogenous Vaccines Sales by Type (2019-2024)
4.1.2 Global Veterinary Autogenous Vaccines Sales by Type (2025-2030)
4.1.3 Global Veterinary Autogenous Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Veterinary Autogenous Vaccines Revenue by Type (2019-2030)
4.2.1 Global Veterinary Autogenous Vaccines Revenue by Type (2019-2024)
4.2.2 Global Veterinary Autogenous Vaccines Revenue by Type (2025-2030)
4.2.3 Global Veterinary Autogenous Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary Autogenous Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Veterinary Autogenous Vaccines Sales by Application (2019-2030)
5.1.1 Global Veterinary Autogenous Vaccines Sales by Application (2019-2024)
5.1.2 Global Veterinary Autogenous Vaccines Sales by Application (2025-2030)
5.1.3 Global Veterinary Autogenous Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Veterinary Autogenous Vaccines Revenue by Application (2019-2030)
5.2.1 Global Veterinary Autogenous Vaccines Revenue by Application (2019-2024)
5.2.2 Global Veterinary Autogenous Vaccines Revenue by Application (2025-2030)
5.2.3 Global Veterinary Autogenous Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary Autogenous Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ZOETIS
6.1.1 ZOETIS Corporation Information
6.1.2 ZOETIS Description and Business Overview
6.1.3 ZOETIS Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ZOETIS Veterinary Autogenous Vaccines Product Portfolio
6.1.5 ZOETIS Recent Developments/Updates
6.2 Ceva Biovac
6.2.1 Ceva Biovac Corporation Information
6.2.2 Ceva Biovac Description and Business Overview
6.2.3 Ceva Biovac Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ceva Biovac Veterinary Autogenous Vaccines Product Portfolio
6.2.5 Ceva Biovac Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Veterinary Autogenous Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Gallant Custom Laboratories
6.4.1 Gallant Custom Laboratories Corporation Information
6.4.2 Gallant Custom Laboratories Description and Business Overview
6.4.3 Gallant Custom Laboratories Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gallant Custom Laboratories Veterinary Autogenous Vaccines Product Portfolio
6.4.5 Gallant Custom Laboratories Recent Developments/Updates
6.5 UVAXX
6.5.1 UVAXX Corporation Information
6.5.2 UVAXX Description and Business Overview
6.5.3 UVAXX Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 UVAXX Veterinary Autogenous Vaccines Product Portfolio
6.5.5 UVAXX Recent Developments/Updates
6.6 Bimeda
6.6.1 Bimeda Corporation Information
6.6.2 Bimeda Description and Business Overview
6.6.3 Bimeda Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bimeda Veterinary Autogenous Vaccines Product Portfolio
6.6.5 Bimeda Recent Developments/Updates
6.7 Dyntec
6.6.1 Dyntec Corporation Information
6.6.2 Dyntec Description and Business Overview
6.6.3 Dyntec Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dyntec Veterinary Autogenous Vaccines Product Portfolio
6.7.5 Dyntec Recent Developments/Updates
6.8 Elanco Animal Health
6.8.1 Elanco Animal Health Corporation Information
6.8.2 Elanco Animal Health Description and Business Overview
6.8.3 Elanco Animal Health Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Elanco Animal Health Veterinary Autogenous Vaccines Product Portfolio
6.8.5 Elanco Animal Health Recent Developments/Updates
6.9 Vaxxinova
6.9.1 Vaxxinova Corporation Information
6.9.2 Vaxxinova Description and Business Overview
6.9.3 Vaxxinova Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vaxxinova Veterinary Autogenous Vaccines Product Portfolio
6.9.5 Vaxxinova Recent Developments/Updates
6.10 Hygieia Biological Laboratories
6.10.1 Hygieia Biological Laboratories Corporation Information
6.10.2 Hygieia Biological Laboratories Description and Business Overview
6.10.3 Hygieia Biological Laboratories Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hygieia Biological Laboratories Veterinary Autogenous Vaccines Product Portfolio
6.10.5 Hygieia Biological Laboratories Recent Developments/Updates
6.11 Deltamune Animal Health
6.11.1 Deltamune Animal Health Corporation Information
6.11.2 Deltamune Animal Health Veterinary Autogenous Vaccines Description and Business Overview
6.11.3 Deltamune Animal Health Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Deltamune Animal Health Veterinary Autogenous Vaccines Product Portfolio
6.11.5 Deltamune Animal Health Recent Developments/Updates
6.12 Genova Labs
6.12.1 Genova Labs Corporation Information
6.12.2 Genova Labs Veterinary Autogenous Vaccines Description and Business Overview
6.12.3 Genova Labs Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Genova Labs Veterinary Autogenous Vaccines Product Portfolio
6.12.5 Genova Labs Recent Developments/Updates
6.13 Newport Laboratories
6.13.1 Newport Laboratories Corporation Information
6.13.2 Newport Laboratories Veterinary Autogenous Vaccines Description and Business Overview
6.13.3 Newport Laboratories Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Newport Laboratories Veterinary Autogenous Vaccines Product Portfolio
6.13.5 Newport Laboratories Recent Developments/Updates
6.14 Epitopix
6.14.1 Epitopix Corporation Information
6.14.2 Epitopix Veterinary Autogenous Vaccines Description and Business Overview
6.14.3 Epitopix Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Epitopix Veterinary Autogenous Vaccines Product Portfolio
6.14.5 Epitopix Recent Developments/Updates
6.15 LOHMANN TIERZUCHT
6.15.1 LOHMANN TIERZUCHT Corporation Information
6.15.2 LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Description and Business Overview
6.15.3 LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Product Portfolio
6.15.5 LOHMANN TIERZUCHT Recent Developments/Updates
6.16 Addison Biological Laboratory
6.16.1 Addison Biological Laboratory Corporation Information
6.16.2 Addison Biological Laboratory Veterinary Autogenous Vaccines Description and Business Overview
6.16.3 Addison Biological Laboratory Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Addison Biological Laboratory Veterinary Autogenous Vaccines Product Portfolio
6.16.5 Addison Biological Laboratory Recent Developments/Updates
6.17 Phibro Animal Health Corporation
6.17.1 Phibro Animal Health Corporation Corporation Information
6.17.2 Phibro Animal Health Corporation Veterinary Autogenous Vaccines Description and Business Overview
6.17.3 Phibro Animal Health Corporation Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Phibro Animal Health Corporation Veterinary Autogenous Vaccines Product Portfolio
6.17.5 Phibro Animal Health Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Autogenous Vaccines Industry Chain Analysis
7.2 Veterinary Autogenous Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Autogenous Vaccines Production Mode & Process
7.4 Veterinary Autogenous Vaccines Sales and Marketing
7.4.1 Veterinary Autogenous Vaccines Sales Channels
7.4.2 Veterinary Autogenous Vaccines Distributors
7.5 Veterinary Autogenous Vaccines Customers
8 Veterinary Autogenous Vaccines Market Dynamics
8.1 Veterinary Autogenous Vaccines Industry Trends
8.2 Veterinary Autogenous Vaccines Market Drivers
8.3 Veterinary Autogenous Vaccines Market Challenges
8.4 Veterinary Autogenous Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Veterinary Autogenous Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Veterinary Autogenous Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Veterinary Autogenous Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Veterinary Autogenous Vaccines Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Veterinary Autogenous Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Veterinary Autogenous Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Veterinary Autogenous Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Veterinary Autogenous Vaccines Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Veterinary Autogenous Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Veterinary Autogenous Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Veterinary Autogenous Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Veterinary Autogenous Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Autogenous Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Autogenous Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Autogenous Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Veterinary Autogenous Vaccines Sales by Region (2019-2024) & (K Doses)
Table 18. Global Veterinary Autogenous Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Veterinary Autogenous Vaccines Sales by Region (2025-2030) & (K Doses)
Table 20. Global Veterinary Autogenous Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Veterinary Autogenous Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Veterinary Autogenous Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Veterinary Autogenous Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Veterinary Autogenous Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Veterinary Autogenous Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Veterinary Autogenous Vaccines Sales by Country (2019-2024) & (K Doses)
Table 27. North America Veterinary Autogenous Vaccines Sales by Country (2025-2030) & (K Doses)
Table 28. North America Veterinary Autogenous Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Veterinary Autogenous Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Veterinary Autogenous Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Veterinary Autogenous Vaccines Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Veterinary Autogenous Vaccines Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Veterinary Autogenous Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Veterinary Autogenous Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Veterinary Autogenous Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Veterinary Autogenous Vaccines Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Veterinary Autogenous Vaccines Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Veterinary Autogenous Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Veterinary Autogenous Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Veterinary Autogenous Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Veterinary Autogenous Vaccines Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Veterinary Autogenous Vaccines Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Veterinary Autogenous Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Veterinary Autogenous Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Veterinary Autogenous Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Veterinary Autogenous Vaccines Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Veterinary Autogenous Vaccines Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Veterinary Autogenous Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Veterinary Autogenous Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Veterinary Autogenous Vaccines Sales (K Doses) by Type (2019-2024)
Table 51. Global Veterinary Autogenous Vaccines Sales (K Doses) by Type (2025-2030)
Table 52. Global Veterinary Autogenous Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Veterinary Autogenous Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Veterinary Autogenous Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Veterinary Autogenous Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Veterinary Autogenous Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Veterinary Autogenous Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Veterinary Autogenous Vaccines Price (US$/Dose) by Type (2019-2024)
Table 59. Global Veterinary Autogenous Vaccines Price (US$/Dose) by Type (2025-2030)
Table 60. Global Veterinary Autogenous Vaccines Sales (K Doses) by Application (2019-2024)
Table 61. Global Veterinary Autogenous Vaccines Sales (K Doses) by Application (2025-2030)
Table 62. Global Veterinary Autogenous Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Veterinary Autogenous Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Veterinary Autogenous Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Veterinary Autogenous Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Veterinary Autogenous Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Veterinary Autogenous Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Veterinary Autogenous Vaccines Price (US$/Dose) by Application (2019-2024)
Table 69. Global Veterinary Autogenous Vaccines Price (US$/Dose) by Application (2025-2030)
Table 70. ZOETIS Corporation Information
Table 71. ZOETIS Description and Business Overview
Table 72. ZOETIS Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. ZOETIS Veterinary Autogenous Vaccines Product
Table 74. ZOETIS Recent Developments/Updates
Table 75. Ceva Biovac Corporation Information
Table 76. Ceva Biovac Description and Business Overview
Table 77. Ceva Biovac Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Ceva Biovac Veterinary Autogenous Vaccines Product
Table 79. Ceva Biovac Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Veterinary Autogenous Vaccines Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Gallant Custom Laboratories Corporation Information
Table 86. Gallant Custom Laboratories Description and Business Overview
Table 87. Gallant Custom Laboratories Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Gallant Custom Laboratories Veterinary Autogenous Vaccines Product
Table 89. Gallant Custom Laboratories Recent Developments/Updates
Table 90. UVAXX Corporation Information
Table 91. UVAXX Description and Business Overview
Table 92. UVAXX Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. UVAXX Veterinary Autogenous Vaccines Product
Table 94. UVAXX Recent Developments/Updates
Table 95. Bimeda Corporation Information
Table 96. Bimeda Description and Business Overview
Table 97. Bimeda Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Bimeda Veterinary Autogenous Vaccines Product
Table 99. Bimeda Recent Developments/Updates
Table 100. Dyntec Corporation Information
Table 101. Dyntec Description and Business Overview
Table 102. Dyntec Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Dyntec Veterinary Autogenous Vaccines Product
Table 104. Dyntec Recent Developments/Updates
Table 105. Elanco Animal Health Corporation Information
Table 106. Elanco Animal Health Description and Business Overview
Table 107. Elanco Animal Health Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Elanco Animal Health Veterinary Autogenous Vaccines Product
Table 109. Elanco Animal Health Recent Developments/Updates
Table 110. Vaxxinova Corporation Information
Table 111. Vaxxinova Description and Business Overview
Table 112. Vaxxinova Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Vaxxinova Veterinary Autogenous Vaccines Product
Table 114. Vaxxinova Recent Developments/Updates
Table 115. Hygieia Biological Laboratories Corporation Information
Table 116. Hygieia Biological Laboratories Description and Business Overview
Table 117. Hygieia Biological Laboratories Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Hygieia Biological Laboratories Veterinary Autogenous Vaccines Product
Table 119. Hygieia Biological Laboratories Recent Developments/Updates
Table 120. Deltamune Animal Health Corporation Information
Table 121. Deltamune Animal Health Description and Business Overview
Table 122. Deltamune Animal Health Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Deltamune Animal Health Veterinary Autogenous Vaccines Product
Table 124. Deltamune Animal Health Recent Developments/Updates
Table 125. Genova Labs Corporation Information
Table 126. Genova Labs Description and Business Overview
Table 127. Genova Labs Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. Genova Labs Veterinary Autogenous Vaccines Product
Table 129. Genova Labs Recent Developments/Updates
Table 130. Newport Laboratories Corporation Information
Table 131. Newport Laboratories Description and Business Overview
Table 132. Newport Laboratories Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 133. Newport Laboratories Veterinary Autogenous Vaccines Product
Table 134. Newport Laboratories Recent Developments/Updates
Table 135. Epitopix Corporation Information
Table 136. Epitopix Description and Business Overview
Table 137. Epitopix Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 138. Epitopix Veterinary Autogenous Vaccines Product
Table 139. Epitopix Recent Developments/Updates
Table 140. LOHMANN TIERZUCHT Corporation Information
Table 141. LOHMANN TIERZUCHT Description and Business Overview
Table 142. LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 143. LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Product
Table 144. LOHMANN TIERZUCHT Recent Developments/Updates
Table 145. Addison Biological Laboratory Corporation Information
Table 146. Addison Biological Laboratory Description and Business Overview
Table 147. Addison Biological Laboratory Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 148. Addison Biological Laboratory Veterinary Autogenous Vaccines Product
Table 149. Addison Biological Laboratory Recent Developments/Updates
Table 150. Phibro Animal Health Corporation Corporation Information
Table 151. Phibro Animal Health Corporation Description and Business Overview
Table 152. Phibro Animal Health Corporation Veterinary Autogenous Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 153. Phibro Animal Health Corporation Veterinary Autogenous Vaccines Product
Table 154. Phibro Animal Health Corporation Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Veterinary Autogenous Vaccines Distributors List
Table 158. Veterinary Autogenous Vaccines Customers List
Table 159. Veterinary Autogenous Vaccines Market Trends
Table 160. Veterinary Autogenous Vaccines Market Drivers
Table 161. Veterinary Autogenous Vaccines Market Challenges
Table 162. Veterinary Autogenous Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Veterinary Autogenous Vaccines
Figure 2. Global Veterinary Autogenous Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Veterinary Autogenous Vaccines Market Share by Type in 2023 & 2030
Figure 4. Pet Vaccine Product Picture
Figure 5. Livestock Vaccine Product Picture
Figure 6. Global Veterinary Autogenous Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Veterinary Autogenous Vaccines Market Share by Application in 2023 & 2030
Figure 8. Research Facility
Figure 9. Pet Clinic
Figure 10. Ranches
Figure 11. Others
Figure 12. Global Veterinary Autogenous Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Veterinary Autogenous Vaccines Market Size (2019-2030) & (US$ Million)
Figure 14. Global Veterinary Autogenous Vaccines Sales (2019-2030) & (K Doses)
Figure 15. Global Veterinary Autogenous Vaccines Average Price (US$/Dose) & (2019-2030)
Figure 16. Veterinary Autogenous Vaccines Report Years Considered
Figure 17. Veterinary Autogenous Vaccines Sales Share by Manufacturers in 2023
Figure 18. Global Veterinary Autogenous Vaccines Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Veterinary Autogenous Vaccines Players: Market Share by Revenue in 2023
Figure 20. Veterinary Autogenous Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Veterinary Autogenous Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Veterinary Autogenous Vaccines Sales Market Share by Country (2019-2030)
Figure 23. North America Veterinary Autogenous Vaccines Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Veterinary Autogenous Vaccines Sales Market Share by Country (2019-2030)
Figure 27. Europe Veterinary Autogenous Vaccines Revenue Market Share by Country (2019-2030)
Figure 28. Germany Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Veterinary Autogenous Vaccines Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Veterinary Autogenous Vaccines Revenue Market Share by Region (2019-2030)
Figure 35. China Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Veterinary Autogenous Vaccines Sales Market Share by Country (2019-2030)
Figure 46. Latin America Veterinary Autogenous Vaccines Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Veterinary Autogenous Vaccines Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Veterinary Autogenous Vaccines Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Veterinary Autogenous Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Veterinary Autogenous Vaccines by Type (2019-2030)
Figure 56. Global Revenue Market Share of Veterinary Autogenous Vaccines by Type (2019-2030)
Figure 57. Global Veterinary Autogenous Vaccines Price (US$/Dose) by Type (2019-2030)
Figure 58. Global Sales Market Share of Veterinary Autogenous Vaccines by Application (2019-2030)
Figure 59. Global Revenue Market Share of Veterinary Autogenous Vaccines by Application (2019-2030)
Figure 60. Global Veterinary Autogenous Vaccines Price (US$/Dose) by Application (2019-2030)
Figure 61. Veterinary Autogenous Vaccines Value Chain
Figure 62. Veterinary Autogenous Vaccines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
